Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes.
Li K, Sun X, Li H, Ma H, Zhou M, Minami K, Tamari K, Ogawa K, Pandya PH, Saadatzadeh MR, Kacena MA, Pollok KE, Li BY, Yokota H.
Li K, et al.
Genes Dis. 2022 Aug 28;10(4):1641-1656. doi: 10.1016/j.gendis.2022.08.007. eCollection 2023 Jul.
Genes Dis. 2022.
PMID: 37397541
Free PMC article.